145 related articles for article (PubMed ID: 15017238)
21. Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy.
Karamanakos P; Mitsiades CS; Lembessis P; Kontos M; Trafalis D; Koutsilieris M
Anticancer Res; 2004; 24(2C):1077-81. PubMed ID: 15154626
[TBL] [Abstract][Full Text] [Related]
22. Fatal fulminant hepatitis from cyproterone acetate.
Hirsch D; Kovatz S; Bernheim J; Shenkman L
Isr J Med Sci; 1994 Mar; 30(3):238-40. PubMed ID: 8181926
[No Abstract] [Full Text] [Related]
23. Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.
Shipley WU; Desilvio M; Pilepich MV; Roach M; Wolkov HB; Sause WT; Rubin P; Lawton CA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1162-7. PubMed ID: 16427211
[TBL] [Abstract][Full Text] [Related]
24. [Experience with therapy of prostate cancer in the Primorye Territory].
Gurina LI; Iudin SV
Vopr Onkol; 2004; 50(5):599-601. PubMed ID: 15715105
[TBL] [Abstract][Full Text] [Related]
25. [Fatal hepatic failure following hepatitis caused by flutamide: a case report].
Okaneya T; Murata Y; Kinebuchi Y
Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):590-3. PubMed ID: 10386060
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
Soga N; Onishi T; Arima K; Sugimura Y
Int J Urol; 2007 Mar; 14(3):192-6; discussion 197. PubMed ID: 17430253
[TBL] [Abstract][Full Text] [Related]
27. Flutamide-induced liver toxicity including fatal hepatic necrosis.
Crownover RL; Holland J; Chen A; Krieg R; Young BK; Roach M; Fu KK
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):911-5. PubMed ID: 8598370
[TBL] [Abstract][Full Text] [Related]
28. What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?
Holzbeierlein JM
Nat Clin Pract Oncol; 2008 Feb; 5(2):74-5. PubMed ID: 17971802
[No Abstract] [Full Text] [Related]
29. [Severe toxic hepatitis during flutamide (Eulexin) treatment].
Møller S; Iversen P
Ugeskr Laeger; 1989 Jan; 151(3):173-4. PubMed ID: 2911917
[TBL] [Abstract][Full Text] [Related]
30. Flutamide induced lupus.
Reid MB; Glode LM
J Urol; 1998 Jun; 159(6):2098. PubMed ID: 9598538
[No Abstract] [Full Text] [Related]
31. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
Miyake H; Hara I; Eto H
BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
[TBL] [Abstract][Full Text] [Related]
32. Anemia in patients on combined androgen block therapy for prostate cancer.
Qian LX; Hua LX; Wu HF; Sui YG; Cheng SG; Zhang W; Li J; Wang XR
Asian J Androl; 2004 Dec; 6(4):383-4. PubMed ID: 15546035
[TBL] [Abstract][Full Text] [Related]
33. Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer--a pilot study.
Sugiono M; Winkler MH; Okeke AA; Benney M; Gillatt DA
Prostate Cancer Prostatic Dis; 2005; 8(1):91-4. PubMed ID: 15711607
[TBL] [Abstract][Full Text] [Related]
34. Fatal liver complications with flutamide.
Osculati A; Castiglioni C
Lancet; 2006 Apr; 367(9517):1140-1. PubMed ID: 16616550
[No Abstract] [Full Text] [Related]
35. Flutamide photosensitivity.
Tsien C; Souhami L
J Urol; 1999 Aug; 162(2):494. PubMed ID: 10411069
[No Abstract] [Full Text] [Related]
36. Flutamide induced methemoglobinemia.
Khan AM; Singh NT; Bilgrami S
J Urol; 1997 Apr; 157(4):1363. PubMed ID: 9120948
[No Abstract] [Full Text] [Related]
37. Watchful waiting beats androgen deprivation therapy in early prostate cancer.
Brower V
J Natl Cancer Inst; 2008 Nov; 100(21):1494-6. PubMed ID: 18957680
[No Abstract] [Full Text] [Related]
38. Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: a retrospective chart review.
Curtis KK; Adam TJ; Chen SC; Pruthi RK; Gornet MK
Aging Male; 2008 Dec; 11(4):157-61. PubMed ID: 18937151
[TBL] [Abstract][Full Text] [Related]
39. The 'flare' phenomenon: should we be concerned?
Thurairaja R; Persad R; Peters J; Bahl A
BJU Int; 2005 Jul; 96(1):4-6. PubMed ID: 15963110
[No Abstract] [Full Text] [Related]
40. Combined androgen blockade: an update.
Klotz L
Urol Clin North Am; 2006 May; 33(2):161-6, v-vi. PubMed ID: 16631454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
